Impax Asset Management Group
CMD

Impax Asset Management Group’s Cantel Medical Corporation CMD Stock Holding History

Impax Asset Management Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-479,188
Closed -$32.1M – 302
2019
Q1 		$32.1M Buy
479,188
+23,512
+5% +$1.78M 0.44% 51
2018
Q4 		$33.9M Buy
455,676
+223,076
+96% +$18.4M 0.55% 50
2018
Q3 		$21.4M Buy
+232,600
New +$22.2M 0.31% 72

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Impax Asset Management Group's CMD Position: Q2 2019 in Review

Impax Asset Management Group sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 479,188 shares — an estimated $32.1M sold.

Impax Asset Management Group first reported a position in CMD in Q3 2018 and held it in 3 quarters. The position peaked at $33.9M in Q4 2018. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Impax Asset Management Group reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Impax Asset Management Group sold 479,188 Cantel Medical Corporation shares in Q2 2019, an estimated $32.1M.
  • Impax Asset Management Group first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 3 quarters.
  • Impax Asset Management Group's Cantel Medical Corporation position peaked at $33.9M in Q4 2018.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Impax Asset Management Group's 13F filing for Q2 2019, filed 13 Aug 2019.